CYTOKINETICS, INCORPORATED Shares Issued
CYTOKINETICS, INCORPORATED (CYTK) had Shares Issued of 122.94 million shares as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-02-26
- 2025-12-31: Common Stock, Shares, Issued 122.94M shares.
- 2024-12-31: Common Stock, Shares, Issued 118.21M shares.
- 2023-12-31: Common Stock, Shares, Issued 101.64M shares.
- 2022-12-31: Common Stock, Shares, Issued 94.83M shares.
| Period end | Common Stock, Shares, Issued | Common Stock, Shares, Issued as first filed |
|---|---|---|
| 2025-12-31 | 122.94M shares 10-K · filed 2026-02-26 | |
| 2024-12-31 | 118.21M shares 10-K · filed 2026-02-26 | |
| 2023-12-31 | 101.64M shares 10-K · filed 2025-02-27 | |
| 2022-12-31 | 94.83M shares 10-K · filed 2024-02-28 | |
| 2021-12-31 | 84.80M shares 10-K · filed 2023-03-01 | |
| 2020-12-31 | 71.02M shares 10-K · filed 2022-02-25 | |
| 2019-12-31 | 59.17M shares 10-K · filed 2021-02-26 | |
| 2018-12-31 | 54.72M shares 10-K · filed 2020-03-04 | |
| 2017-12-31 | 53.96M shares 10-K · filed 2019-03-07 | |
| 2017-09-30 | 53.86M shares 10-Q · filed 2017-11-03 | |
| 2017-06-30 | 53.46M shares 10-Q · filed 2017-08-04 | |
| 2017-03-31 | 43.42M shares 10-Q · filed 2017-05-04 | |
| 2016-12-31 | 40.65M shares 10-K · filed 2018-03-05 | |
| 2016-09-30 | 40.52M shares 10-Q/A · filed 2016-12-15 | |
| 2016-06-30 | 39.70M shares 10-Q · filed 2016-08-04 | |
| 2016-03-31 | 39.61M shares 10-Q · filed 2016-05-05 | |
| 2015-12-31 | 39.58M shares 10-K · filed 2017-03-06 | |
| 2015-09-30 | 38.76M shares 10-Q · filed 2015-11-05 | |
| 2015-06-30 | 38.73M shares 10-Q · filed 2015-08-05 | |
| 2015-03-31 | 38.72M shares 10-Q · filed 2015-05-04 | |
| 2014-12-31 | 38.66M shares 10-K · filed 2016-03-03 | |
| 2014-09-30 | 36.61M shares 10-Q · filed 2014-11-06 | |
| 2014-06-30 | 36.61M shares 10-Q · filed 2014-08-07 | |
| 2014-03-31 | 36.09M shares 10-Q · filed 2014-05-07 | |
| 2013-12-31 | 30.68M shares 10-K · filed 2015-03-06 | |
| 2013-09-30 | 29.50M shares 10-Q · filed 2013-11-06 | |
| 2013-06-30 | 28.69M shares 10-Q · filed 2013-08-07 | |
| 2013-03-31 | 146.46M shares 10-Q · filed 2013-05-08 | |
| 2012-12-31 | 23.74M shares 10-K · filed 2014-03-07 | 142.46M shares 10-K · filed 2013-03-15 |
| 2012-09-30 | 142.41M shares 10-Q · filed 2012-11-07 | |
| 2012-06-30 | 133.48M shares 10-Q · filed 2012-08-06 | |
| 2012-06-25 | 9.32M shares 10-K · filed 2017-03-06 | 55.92M shares 10-K · filed 2013-03-15 |
| 2012-03-31 | 77.51M shares 10-Q · filed 2012-05-04 | |
| 2011-12-31 | 74.92M shares 10-K · filed 2013-03-15 | |
| 2011-09-30 | 72.28M shares 10-Q · filed 2011-11-04 | |
| 2011-06-30 | 72.28M shares 10-Q · filed 2011-08-04 | |
| 2010-12-31 | 66.91M shares 10-K · filed 2012-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |